http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-353658-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e493dbb326bdb84242fbc9af833f128e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-04
filingDate 1994-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db1823f0bdc8444aeef81d6f920e1c51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d68ccc6c0223b41c4d34ff9e9871dee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0fd3f9a96cd8e4485b79ed72da83a89
publicationDate 1999-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-353658-B
titleOfInvention Substituted tetrahydroisoquinoline compounds, pharmaceutical compositions containing them, and processes for their preparation
abstract A tetrahydroisoquinoline compounds of formula I, and pharmaceutically acceptable salts thereof, in which: R1 represents C1-C3-alkyl; R2 represents C1-C3-alkyl; E represents C2-C3-alkenyl chain; and G represents (a) saturated or unsaturated alicyclic group containing 3 to 8 carbon atoms; (b) C1-C6-alkyl optionally substituted by C1-C3-alkyl or C3-C7-cycloalkyl; or (c) pyridyl, furyl, thienyl or naphthyl.
priorityDate 1993-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456485498

Total number of triples: 35.